TG Therapeutics Inc (TGTX)
Healthcare
Biotechnology
52.00 $
-2.8%
vs. previous close
Closing price · As of: 31. Jul 2026
TG Therapeutics Inc (TGTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -18 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -42 | 84 | -13 | -8.2 | 5.5 | -12 | -26 | -29 | 7.4 | -23 | 20 | -18 | -14 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 7.5 | 0.1 | 7.7 | |
| 13 | 9.2 | 9.4 | 9.3 | 9.5 | 12 | 12 | 15 | 16 | 18 | 16 | 20 | 70 | |
| 13 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -8.2 | -40 | -8.1 | -6.1 | -11 | -32 | -61 | -49 | -37 | -65 | -45 | -70 | -216 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | |
| 31 | -30 | -45 | -9.3 | 1.8 | -9.3 | 16 | -13 | -4.0 | 46 | -16 | -9.9 | 17 | |
| 0.0 | 0.0 | – | – | – | – | – | 0.0 | – | – | – | 0.0 | – | |
| 47 | – | 0.0 | 0.0 | 0.0 | -2.1 | -6.6 | -6.1 | -6.9 | -78 | -19 | -100 | -204 | |
| – | – | – | – | – | 137 | 0.0 | 0.0 | – | – | 0.0 | 493 | – | |
| 47 | 0.4 | 0.0 | 0.0 | 0.1 | 134 | -6.1 | -6.1 | -6.4 | -78 | 1.1 | 391 | 307 | |
| 36 | 54 | -58 | -17 | 7.4 | 113 | -16 | -48 | -3.0 | -55 | 5.1 | 363 | 310 | |
| -42 | 84 | -13 | -8.2 | 5.5 | -12 | -26 | -29 | 7.4 | -23 | 20 | -18 | -14 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.